These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22474082)

  • 1. Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion.
    Fitter S; Vandyke K; Gronthos S; Zannettino AC
    J Mol Endocrinol; 2012 Jun; 48(3):229-40. PubMed ID: 22474082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y; Jia L; Wang X; Tan X; Xu J; Deng Z; Jiang T; Rainov NG; Li B; Ren H
    Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
    Artemenko Y; Gagnon A; Sorisky A
    J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: a mechanism for improved insulin sensitivity in type 2 diabetic CML patients?
    Fitter S; Vandyke K; Schultz CG; White D; Hughes TP; Zannettino AC
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3763-7. PubMed ID: 20466781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
    Kinoshita K; Nakagawa K; Hamada J; Hida Y; Tada M; Kondo S; Moriuchi T
    Int J Oncol; 2010 Oct; 37(4):869-77. PubMed ID: 20811709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway.
    Bauer S; Duensing A; Demetri GD; Fletcher JA
    Oncogene; 2007 Nov; 26(54):7560-8. PubMed ID: 17546049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preadipocyte apoptosis is prevented by macrophage-conditioned medium in a PDGF-dependent manner.
    Molgat AS; Gagnon A; Sorisky A
    Am J Physiol Cell Physiol; 2009 Apr; 296(4):C757-65. PubMed ID: 19225164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
    Leipner C; Grün K; Müller A; Buchdunger E; Borsi L; Kosmehl H; Berndt A; Janik T; Uecker A; Kiehntopf M; Böhmer FD
    Cardiovasc Res; 2008 Jul; 79(1):118-26. PubMed ID: 18326555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.
    Kim ED; Kim E; Lee JH; Hyun CK
    Eur J Pharmacol; 2011 Jan; 650(1):479-85. PubMed ID: 20951125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term imatinib therapy promotes bone formation in CML patients.
    Fitter S; Dewar AL; Kostakis P; To LB; Hughes TP; Roberts MM; Lynch K; Vernon-Roberts B; Zannettino AC
    Blood; 2008 Mar; 111(5):2538-47. PubMed ID: 18042796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
    Campbell JS; Johnson MM; Bauer RL; Hudkins KL; Gilbertson DG; Riehle KJ; Yeh MM; Alpers CE; Fausto N
    Differentiation; 2007 Nov; 75(9):843-52. PubMed ID: 17999742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells.
    Cho SY; Park PJ; Shin HJ; Kim YK; Shin DW; Shin ES; Lee HH; Lee BG; Baik JH; Lee TR
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1166-72. PubMed ID: 17164435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy.
    Zhao P; Deng Y; Gu P; Wang Y; Zhou H; Hu Y; Chen P; Fan X
    Exp Eye Res; 2013 Feb; 107():65-73. PubMed ID: 23219871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of focal adhesion kinase in BMP4 induction of mesenchymal stem cell adipogenesis.
    Lee JS; Ha L; Kwon IK; Lim JY
    Biochem Biophys Res Commun; 2013 Jun; 435(4):696-701. PubMed ID: 23702483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors.
    Dewar AL; Domaschenz RM; Doherty KV; Hughes TP; Lyons AB
    Leukemia; 2003 Sep; 17(9):1713-21. PubMed ID: 12970769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development.
    Burchert A; Wang Y; Cai D; von Bubnoff N; Paschka P; Müller-Brüsselbach S; Ottmann OG; Duyster J; Hochhaus A; Neubauer A
    Leukemia; 2005 Oct; 19(10):1774-82. PubMed ID: 16136169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive diffuse activation of phosphoinositide 3-kinase at the plasma membrane by v-Src suppresses the chemotactic response to PDGF by abrogating the polarity of PDGF receptor signalling.
    Platek A; Vassilev VS; de Diesbach P; Tyteca D; Mettlen M; Courtoy PJ
    Exp Cell Res; 2007 Apr; 313(6):1090-105. PubMed ID: 17335807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR-ABL- and Ras-independent activation of Raf as a novel mechanism of Imatinib resistance in CML.
    Hentschel J; Rubio I; Eberhart M; Hipler C; Schiefner J; Schubert K; Loncarevic IF; Wittig U; Baniahmad A; von Eggeling F
    Int J Oncol; 2011 Sep; 39(3):585-91. PubMed ID: 21637917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.